Investment Thesis
NIMU is technically insolvent with negative stockholders equity of -$989K, virtually zero revenue ($6K), and massive operating losses exceeding 700% of revenue. The company burns cash with no operational profitability or liquidity to service its $2.1M debt burden, indicating imminent bankruptcy risk.
Strengths
- Company still operationally active in electromedical sector
- Some long-term debt indicates prior creditor confidence
- Minimal cash burn rate given scale ($22K annually)
Risks
- Negative stockholders equity - company is balance sheet insolvent
- Insufficient liquidity - current ratio of 0.01x cannot meet obligations
- Revenue collapse with $6K annual revenue and zero growth momentum
- Debt burden of $2.1M long-term debt plus $995K liabilities vastly exceeds $6K in total assets
- Persistent negative operating cash flow with no path to profitability
- Zero insider activity suggests abandonment by management
Key Metrics to Watch
- Stockholders equity recovery (currently -$989K)
- Operating cash flow sustainability (currently -$22K)
- Debt restructuring or default events
- Revenue generation inflection (currently $6K, needs 100x+ growth)
Financial Metrics
Revenue
6.0K
Net Income
-42.0K
EPS (Diluted)
$0.00
Free Cash Flow
-22.0K
Total Assets
6.0K
Cash
6.0K
Profitability Ratios
Gross Margin
N/A
Operating Margin
-416.7%
Net Margin
-700.0%
ROE
N/A
ROA
-700.0%
FCF Margin
-366.7%
Balance Sheet & Liquidity
Current Ratio
0.01x
Quick Ratio
-0.09x
Debt/Equity
N/A
Debt/Assets
16,583.3%
Interest Coverage
-1.47x
Long-term Debt
2.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-13T06:39:19.157260 |
Data as of: 2025-10-31 |
Powered by Claude AI